Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TYRA is expected to report earnings to rise 6.76% to -53 cents per share on March 25
Q4'25
Est.
$-0.53
Q3'25
Est.
$-0.50
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.05
The last earnings report on November 05 showed earnings per share of -50 cents, meeting the estimate of -50 cents. With 117.66K shares outstanding, the current market capitalization sits at 826.73M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TYRA showed earnings on November 05, 2025. You can read more about the earnings report here.